Company Edwards Lifesciences Corporation

Equities

EW

US28176E1082

Advanced Medical Equipment & Technology

Real-time Estimate Cboe BZX 12:43:17 2023-12-07 pm EST Intraday chart for Edwards Lifesciences Corporation 5-day change 1st Jan Change
67.38 USD -3.04% -0.53% -9.73%

Business Summary

Edwards Lifesciences Corporation specializes in designing, manufacturing and marketing medical systems and devices for treating cardiovascular diseases. Net sales break down by family of products as follows:

- hemodynamic monitoring systems (65.4%);

- heart valves and surgery products (18.7%);

- other (15.9%): balloon catheters, artificial implants, etc.

Net sales are distributed geographically as follows: the United States (58.2%), Europe (21.8%), Japan (8.8%) and other (11.2%).

Number of employees : 17,300

Sales per Business

USD in Million2021Weight2022Weight Delta
Transcatheter Aortic Valve Replacement
65.4 %
3,423 65.4 % 3,518 65.4 % +2.80%
Surgical Structural Heart
16.6 %
889 17.0 % 893 16.6 % +0.45%
Critical Care
15.9 %
835 16.0 % 855 15.9 % +2.41%
Transcatheter Mitral and Tricuspid Therapies
2.2 %
86 1.6 % 116 2.2 % +35.00%

Sales per region

USD in Million2021Weight2022Weight Delta
United States
58.2 %
2,963 56.6 % 3,133 58.2 % +5.72%
Europe
21.8 %
1,190 22.7 % 1,175 21.8 % -1.30%
Rest of World
11.2 %
550 10.5 % 601 11.2 % +9.31%
Japan
8.8 %
529 10.1 % 474 8.8 % -10.46%

Managers

Managers TitleAgeSince
Chief Executive Officer 56 2014
Director of Finance/CFO 56 2013
Chairman 70 1999
Chief Tech/Sci/R&D Officer - 2019
Investor Relations Contact - -
General Counsel 45 -
Corporate Officer/Principal 64 2017
Corporate Officer/Principal - 2011
Corporate Officer/Principal 61 1994
Corporate Officer/Principal 56 2014

Members of the board

Members of the board TitleAgeSince
Director/Board Member 62 2016
Director/Board Member 66 2014
Director/Board Member 71 2016
Chairman 70 1999
Director/Board Member 65 2020
Director/Board Member 59 2015
Director/Board Member 74 2015
Director/Board Member 57 2020
Chief Executive Officer 56 2014

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 649,900,000 601,270,967 ( 92.52 %) 43,400,000 ( 6.678 %) 92.52 %

Shareholders

NameEquities%Valuation
The Vanguard Group, Inc.
8.262 %
50,106,434 8.262 % 3 193 M $
AllianceBernstein LP
2.800 %
16,981,861 2.800 % 1 082 M $
Capital Research & Management Co. (Global Investors)
2.542 %
15,420,202 2.542 % 983 M $
Capital Research & Management Co. (World Investors)
2.099 %
12,733,292 2.099 % 811 M $
Wellington Management Co. LLP
2.066 %
12,530,027 2.066 % 798 M $
Geode Capital Management LLC
1.947 %
11,808,998 1.947 % 752 M $
Norges Bank Investment Management
1.455 %
8,824,423 1.455 % 562 M $
Union Investment Privatfonds GmbH
1.170 %
7,094,508 1.170 % 452 M $
Janus Henderson Investors US LLC
0.7133 %
4,326,167 0.7133 % 276 M $
4,042,863 0.6666 % 258 M $

Company contact information

Edwards Lifesciences Corp.

1209 Orange Street

19801, Wilmington

+949 250 2500

http://www.edwards.com
address Edwards Lifesciences Corporation(EW)

Group companies

NameCategory and Sector
Edwards Lifesciences World Trade Corp.
Health Technology - Medical Specialties
Edwards Lifesciences Technology SARL
-
Edwards Lifesciences (India) Pvt Ltd.
Health Technology - Medical Specialties
  1. Stock
  2. Equities
  3. Stock Edwards Lifesciences Corporation - Nyse
  4. Company Edwards Lifesciences Corporation
Discover our Free Content to Help You Better Understand the Stock Market.
100% Free Registration
fermer